Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toyofumi Yamaguchi is active.

Publication


Featured researches published by Toyofumi Yamaguchi.


Journal of Biological Chemistry | 2000

Dehydroaltenusin, a Mammalian DNA Polymerase α Inhibitor

Yoshiyuki Mizushina; Shinji Kamisuki; Takeshi Mizuno; Masaharu Takemura; Hitomi Asahara; Stuart Linn; Toyofumi Yamaguchi; Akio Matsukage; Fumio Hanaoka; Shonen Yoshida; Mineo Saneyoshi; Fumio Sugawara; Kengo Sakaguchi

Dehydroaltenusin was found to be an inhibitor of mammalian DNA polymerase α (pol α) in vitro. Surprisingly, among the polymerases and DNA metabolic enzymes tested, dehydroaltenusin inhibited only mammalian pol α. Dehydroaltenusin did not influence the activities of the other replicative DNA polymerases, such as δ and ε; it also showed no effect even on the pol α activity from another vertebrate (fish) or plant species. The inhibitory effect of dehydroaltenusin on mammalian pol α was dose-dependent, and 50% inhibition was observed at a concentration of 0.5 μm. Dehydroaltenusin-induced inhibition of mammalian pol α activity was competitive with the template-primer and non-competitive with the dNTP substrate. BIAcore analysis demonstrated that dehydroaltenusin bound to the core domain of the largest subunit, p180, of mouse pol α, which has catalytic activity, but did not bind to the smallest subunit or the DNA primase p46 of mouse pol α. These results suggest that the dehydroaltenusin molecule competes with the template-primer molecule on its binding site of the catalytic domain of mammalian pol α, binds to the site, and simultaneously disturbs dNTP substrate incorporation into the template-primer.


Biochemical Journal | 2003

A sulphoquinovosyl diacylglycerol is a DNA polymerase e inhibitor

Yoshiyuki Mizushina; Xianai Xu; Hitomi Asahara; Ryo Takeuchi; Masahiko Oshige; Noriko Shimazaki; Masaharu Takemura; Toyofumi Yamaguchi; Kazufumi Kuroda; Stuart Linn; Hiromi Yoshida; Osamu Koiwai; Mineo Saneyoshi; Fumio Sugawara; Kengo Sakaguchi

Sulphoquinovosyl diacylglycerol (SQDG) was reported as a selective inhibitor of eukaryotic DNA polymerases alpha and beta [Hanashima, Mizushina, Ohta, Yamazaki, Sugawara and Sakaguchi (2000) Jpn. J. Cancer Res. 91, 1073-1083] and an immunosuppressive agent [Matsumoto, Sahara, Fujita, Shimozawa, Takenouchi, Torigoe, Hanashima, Yamazaki, Takahashi, Sugawara et al. (2002) Transplantation 74, 261-267]. The purpose of this paper is to elucidate the biochemical properties of the inhibition more precisely. As expected, SQDG could inhibit the activities of mammalian DNA polymerases such as alpha, delta, eta and kappa in vitro in the range of 2-5 micro M, and beta and lambda in vitro in the range of 20-45 micro M. However, SQDG could inhibit only mammalian DNA polymerases epsilon (pol epsilon) activity at less than 0.04 micro M. SQDG bound more tightly to mammalian pol epsilon than the other mammalian polymerases tested. Moreover, SQDG could inhibit the activities of all the polymerases from animals such as fish and insect, but not of the polymerases from plant and prokaryotes. SQDG should, therefore, be called a mammalian pol epsilon-specific inhibitor or animal polymerase-specific inhibitor. To our knowledge, this represents the first report about an inhibitor specific to mammalian pol epsilon.


Nucleic Acids Research | 2007

3′-Azido-2′,3′-dideoxynucleoside 5′-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells

Xiaohong Liu; Hazuki Takahashi; Yoko Harada; Tsukasa Ogawara; Yuta Ogimura; Yoshiyuku Mizushina; Mineo Saneyoshi; Toyofumi Yamaguchi

Telomerase adds telomeric DNA repeats to the ends of linear chromosomal DNA. 3′-Azido-3′-deoxythymidine 5′-triphosphate (AZTTP) is a known telomerase inhibitor. To obtain more selective and potent inhibitors that can be employed as tools for studying telomerase, we investigated the telomerase-inhibitory effects of purine nucleosides bearing a 3′-down azido group: 3′-azido-2′,3′-dideoxyguanosine (AZddG) 5′-triphosphate (AZddGTP), 3′-azido-2′,3′-dideoxy-6-thioguanosine (AZddSG) 5′-triphosphate (AZddSGTP), 3′-azido-2′,3′-dideoxyadenosine (AZddA) 5′-triphosphate (AZddATP) and 3′-azido-2′,3′-dideoxy-2-aminoadenosine (AZddAA) 5′-triphosphate (AZddAATP). Of these, AZddGTP showed the most potent inhibitory activity against HeLa cell telomerase. AZddGTP was significantly incorporated into the 3′-terminus of DNA by partially purified telomerase. However, AZddGTP did not exhibit significant inhibitory activity against DNA polymerases α and δ, suggesting that AZddGTP is a selective inhibitor of telomerase. We also investigated whether long-term treatment with these nucleosides could alter telomere length and growth rates of human HL60 cells in culture. Southern hybridization analysis of genomic DNA prepared from cells cultured in the presence of AZddG and AZddAA revealed reproducible telomere shortening.


Biochimica et Biophysica Acta | 2000

The biochemical mode of inhibition of DNA polymerase β by α-rubromycin

Yoshiyuki Mizushina; Takamasa Ueno; Masako Oda; Toyofumi Yamaguchi; Mineo Saneyoshi; Kengo Sakaguchi

Quinone antibiotics, alpha- and beta-rubromycin, were originally found as inhibitors of retroviral reverse transcriptase. We investigated the effects of these agents on DNA metabolic enzymes including DNA and RNA polymerases as retroviral reverse transcriptase is a kind of the polymerase. As expected, we found that alpha- and beta-rubromycin strongly inhibited not only the retroviral reverse transcriptase activity, but the activities of the mammalian DNA polymerases, telomerase and terminal deoxynucleotidyl transferase in vitro. These agents should therefore be classified as DNA polymerase inhibitors. The Ki values of alpha-rubromycin against nucleotide substrate were 0.66 and 0.17 microM for DNA polymerase alpha and beta (pol. alpha and beta), respectively, and those of beta-rubromycin was 2.40 and 10.5 microM, respectively. Alpha-rubromycin strongly inhibited the pol. beta activity, and showed the strongest pol. beta inhibitory effect reported to date. At least on pol. beta, alpha-rubromycin was suggested to bind to the active region competing with the nucleotide substrate, and subsequently inhibit the catalytic activity. alpha-Rubromycin directly competed with the nucleotide substrate, and indirectly but simultaneously and non-competitively disturbed the template-DNA interaction with pol. beta.


Antimicrobial Agents and Chemotherapy | 2008

Establishment of a Cell-Based Assay for Screening of Compounds Inhibiting Very Early Events in the Cytomegalovirus Replication Cycle and Characterization of a Compound Identified Using the Assay

Yoshiko Fukui; Keiko Shindoh; Yumiko Yamamoto; Shin Koyano; Isao Kosugi; Toyofumi Yamaguchi; Ichiro Kurane; Naoki Inoue

ABSTRACT To simplify the detection of infectious human cytomegalovirus (HCMV), we generated a cell line that produced luciferase in a dose-dependent manner upon HCMV infection. Using this cell line, we identified anti-HCMV compounds from a diverse library of 9,600 compounds. One of them, 1-(3,5-dichloro-4-pyridyl)piperidine-4-carboxamide (DPPC), was effective against HCMV (Towne strain) infection of human lung fibroblast cells at a 50% effective concentration of 2.5 μM. DPPC also inhibited the growth of clinical HCMV isolates and guinea pig and mouse cytomegaloviruses. Experiments using various time frames for treatment of the cells with DPPC demonstrated that DPPC was effective during the first 24 h after HCMV infection. DPPC treatment decreased not only viral DNA replication but also IE1 and IE2 expression at mRNA and protein levels in the HCMV-infected cells. However, DPPC did not inhibit the attachment of HCMV particles to the cell surface. DPPC is a unique compound that targets the very early phase of cytomegalovirus infection, probably by disrupting a pathway that is important after viral entry but before immediate-early gene expression.


Nucleosides, Nucleotides & Nucleic Acids | 1997

Antileukemic Activities and Mechanism of Action of 2′-Deoxy-4′-methylcytidine and Related Nucleosides

Toyofumi Yamaguchi; Aki Tomikawa; Toshiaki Hirai; Takeo Kawaguchi; Hiroshi Ohrui; Mineo Saneyoshi

Abstract Antileukemic activity of several analogues containing 2′-deoxy-4′-methylcytidine and its araC counterpart were evaluated against murine leukemic P388 cells in vitro and in vivo. Both compounds showed significant cytostatic activity (both IC50=0.4 μM) in vitro and the former compound administered intraperitoneally at a dose of 3 mg/kg/day × 5 showed high activity (T/C=175%) in vivo. The mechanism of action of these 5′-triphosphates on DNA polymerases in detail will be also described.


Nucleosides, Nucleotides & Nucleic Acids | 2006

Synthetic Nucleosides and Nucleotides. 43. Inhibition of Vertebrate Telomerases by Carbocyclic Oxetanocin G (C.OXT-G) Triphosphate Analogues and Influence of C.OXT-G Treatment on Telomere Length in Human HL60 Cells

Toyofumi Yamaguchi; Mineo Saneyoshi; Hazuki Takahashi; Sachiko Hirokawa; Rie Amano; Xiaohong Liu; Motoko Inomata; Tokumi Maruyama

Telomerase, responsible for telomere synthesis, is expressed in ∼ 90% of human tumor cells but seldom in normal somatic cells. In this study, inhibition by carbocyclic oxetanocin G triphosphate (C.OXT-GTP) and its analogues was investigated in order to clarify the susceptibility of telomerase to various nucleotide analogues. C.OXT-GTP competitively inhibited telomerase activity with respect to dGTP. However, C.OXT-GTP had a potent inhibitory effect on DNA polymerase α. It was examined whether the nucleoside (C.OXT-G) was able to alter telomere length in cultured human HL60 cells. Contrary to expectation, long-term treatment with 10 μM C.OXT-G was found to cause telomere lengthening.


Biochimica et Biophysica Acta | 2003

Kohamaic acid A, a novel sesterterpenic acid, inhibits activities of DNA polymerases from deuterostomes

Yoshiyuki Mizushina; Chikako Murakami; Kentaro Yogi; Katsuhiro Ueda; Tomomi Ishidoh; Masaharu Takemura; Marinela Perpelescu; Motoshi Suzuki; Masahiko Oshige; Toyofumi Yamaguchi; Mineo Saneyoshi; Hiromi Yoshida; Kengo Sakaguchi

We previously found and isolated a novel natural product, designated kohamaic acid A (KA-A), which inhibited the first cleavage of fertilized sea urchin eggs. In this paper, we report that this compound could selectively inhibit the activities of DNA polymerases (pol. alpha, beta, gamma, delta and epsilon ) only from species in the deuterostome branch in the animal kingdom, like sea urchin, fish and mammals, but not from protostomes including insects (fruit fly, Drosophila melanogaster) and mollusks (octopus and oyster). Inhibition of deuterostome DNA polymerases was dose dependent. IC(50) values for DNA polymerases of mammals and fish occurred at approximately 5.8-14.9 microM and those of sea urchin at 6.1-30.3 microM. In the sea urchin DNA polymerases, the activities of the replicative DNA polymerases such as alpha, delta and epsilon were more strongly inhibited than that of the repair-related pol. beta. KA-A is an inhibitor of replicative DNA polymerases from the deuterostome species, and subsequently, the inhibition of the first cleavage of fertilized sea urchin eggs might occur as a result of the suppression of DNA replication.


Nucleosides, Nucleotides & Nucleic Acids | 1996

Synthetic Nucleoside and Nucleotides. XXXIV. Photoaffinity Labeling of HIV Reverse Transcriptase: Synthesis and Utilization of 2′,3′-Dideoxy Uridylate Analogs Bearing Aryl(trifluor0methyl)-Diazirine Moiety † 1

Toyofumi Yamaguchi; Mineo Saneyoshi

Abstract In order to develop a photoaffinity labeling reagent for HIV-1 reverse transcriptase, a 2′,3′-dideoxyUTP analog bearing a photo-reactive group at the 5-position of the uracil ring, 2′,3′-dideoxy-E-5-[4-[3-(trifluoromethyl)-3Hdiazirin-3-yl]styryl]-UTP, was designed and synthesized. This photo-reactive analog could preferentially bind to the 66 kDa subunit of the p66/p51 heterodimeric HIV-1 reverse transcriptase under irradiation by near-ultraviolet light (365 nm). (1) Part XXXIII of this series: Kawaguchi, T.; Sakairi, H.; Kimura, S.; Yamaguchi, T.; Saneyoshi, M. Chem. Pharm. Bull. 1995, 43, 501–504. †This paper is dedicated to Dr. Yoshihisa Mizuno on occasion of his 75th birthday.


Nucleosides, Nucleotides & Nucleic Acids | 2007

Telomere Shortening in Human HL60 Cells by Treatment with 3′-Azido-2′,3′-Dideoxynucleosides and Telomerase Inhibition by Their 5′-Triphosphates

Xiaohong Liu; Motoko Inomata; Tsukasa Ogawara; Mineo Saneyoshi; Toyofumi Yamaguchi

Telomerase is thought to play an important role in the mechanism of tumor cell immortalization by maintenance of telomere length. To obtain information on the susceptibility of telomerase to nucleoside analogues, the effects of base-modified 3′-azido-2′,3′-dideoxynucleoside triphosphates on the enzyme were investigated. It is suggested that the 2-amino group of the nucleotide purine nucleus is important for the inhibitory activity. Telomere shortening caused by long-term treatment with these nucleosides is also described.

Collaboration


Dive into the Toyofumi Yamaguchi's collaboration.

Top Co-Authors

Avatar

Mineo Saneyoshi

University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aki Tomikawa

University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Hazuki Takahashi

University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Tsukasa Ogawara

University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Akio Matsukage

Japan Women's University

View shared research outputs
Researchain Logo
Decentralizing Knowledge